Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis.
Mahmood DFD, Jguirim-Souissi I, Khadija EH, Blondeau N, Diderot V, Amrani S, Slimane MN, Syrovets T, Simmet T, Rouis M. Mahmood DFD, et al. Among authors: slimane mn. J Biol Chem. 2011 Aug 19;286(33):28858-28866. doi: 10.1074/jbc.M111.273292. Epub 2011 Jun 23. J Biol Chem. 2011. PMID: 21700710 Free PMC article.
Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.
Abderrazak A, Couchie D, Mahmood DF, Elhage R, Vindis C, Laffargue M, Matéo V, Büchele B, Ayala MR, El Gaafary M, Syrovets T, Slimane MN, Friguet B, Fulop T, Simmet T, El Hadri K, Rouis M. Abderrazak A, et al. Among authors: slimane mn. Circulation. 2015 Mar 24;131(12):1061-70. doi: 10.1161/CIRCULATIONAHA.114.013730. Epub 2015 Jan 22. Circulation. 2015. PMID: 25613820
Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet.
Abderrazak A, El Hadri K, Bosc E, Blondeau B, Slimane MN, Büchele B, Simmet T, Couchie D, Rouis M. Abderrazak A, et al. Among authors: slimane mn. J Pharmacol Exp Ther. 2016 Jun;357(3):487-94. doi: 10.1124/jpet.116.232934. Epub 2016 Apr 4. J Pharmacol Exp Ther. 2016. PMID: 27044804
Response to Letter Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".
Abderrazak A, Couchie D, Darweesh Mahmood DF, Elhage R, Vindis C, Laffargue M, Matéo V, Büchele B, Ayala MR, Gaafary ME, Syrovets T, Slimane MN, Friguet B, Fulop T, Simmet T, Hadri KE, Rouis M. Abderrazak A, et al. Among authors: slimane mn. Circulation. 2015 Nov 24;132(21):e250-1. doi: 10.1161/CIRCULATIONAHA.115.017739. Circulation. 2015. PMID: 26596983 No abstract available.
Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development.
Cuaz-Pérolin C, Jguirim I, Larigauderie G, Jlassi A, Furman C, Moreau M, Chapman MJ, Fruchart JC, Slimane MN, Mezdour H, Rouis M. Cuaz-Pérolin C, et al. Among authors: slimane mn. J Vasc Res. 2006;43(6):493-501. doi: 10.1159/000095309. Epub 2006 Aug 24. J Vasc Res. 2006. PMID: 16931892
38 results